Inhaled Insulin???

Inhaled Insulin???

Phase 3 Studies of Afrezza Ultra-fast Inhaled Insulin On May 31 and June 17, MannKind announced that it had completed its new phase 3 clinical studies of Afrezza for people with type 1 and 2 diabetes. As a reminder, Afrezza is an ultra-rapid-acting mealtime insulin...

ADA: Weak Support for Carb Counting in T1D

By Kristina Fiore, Staff Writer, MedPage Today Reviewed by Robert Jasmer, MD; Associate Clinical Professor of Medicine, University of California, San Francisco and Dorothy Caputo, MA, BSN, RN, Nurse Planner Published June 23, 2013 Action Points This study was...

Replacing Clinicians With Algorithms

www.medscape.com Eric J. Topol, MD Jul 01, 2013 Hello. I’m Dr. Eric Topol, Director of the ScrippsTranslational Science Institute and [Editor-in-Chief of Medscape]. In this series, The Creative Destruction of Medicine, named for the book I wrote, I’m...

The BIONIC PANCREAS: a test drive …

Kelly Close, editor-in-chief of diatribe, writes, in the June issue of diatribe about her experiences on a 5-day trial on the bionic pancreas:   I’m now exactly eleven days out of the five-day Boston University/Massachusetts General Hospital bionic pancreas1...
We Recommend This Book: Cheating Destiny

We Recommend This Book: Cheating Destiny

Cheating Destiny:  Living with Diabetes by James S. Hirsch In Cheating Destiny, the best-selling author James S. Hirsch offers an incisive, sometimes surprising portrait of diabetes in America. Hirsch is intimately familiar with the disease: he has lived with type 1...